Connor Iapoce is an associate editor for HCPLive and joined the MJH Life Sciences team in April 2021. He graduated from The College of New Jersey with a degree in Journalism and Professional Writing. He enjoys listening to records, going to concerts, and playing with his cat Squish. You can reach him at ciapoce@mjhlifesciences.com.
First-Line Bevacizumab Cost-Effective for Macular Edema Due to CRVO or HRVO
May 19th 2023An economic evaluation of the SCORE2 trial indicates aflibercept treatment was unlikely to meet most accepted standards of cost-effectiveness, due to little difference in visual acuity outcomes and a large cost differential compared with bevacizumab.
Read More
Study Suggests Need for Improved Glaucoma Screening by Eye Care Providers
May 17th 2023A lack of a significant refractive error and visiting an optometrist rather than an ophthalmologist were factors associated with a missed diagnosis of primary open-angle glaucoma, according to a recent analysis.
Read More
Higher Prevalence of Diabetic Retinopathy Observed in Patients with T2D, Diabetic Nephropathy
May 11th 2023Logistic regression analysis indicated that higher stages of urine albumin creatine ratio were significantly associated with diabetic retinopathy in patients with T2D and diabetic nephropathy.
Read More
New Insight: A Changing Landscape of Retinal Therapeutics with Charles Wykoff, MD, PhD
May 10th 2023In this episode, Charles Wykoff, MD, PhD joins Dr. Sheth to provide insight into the recent landmark approval of pegcetacoplan injection (SYFOVRE™) for geographic atrophy, how clinical practice has changed as a result, and both the early struggles with and optimism for an ever-changing treatment landscape.
Read More
Ophthalmology Month in Review: April 2023
May 3rd 2023Each month, our editorial staff compiles a recap of the top news in ophthalmology from the past month. Our April 2023 month-in-review features data on the association between social determinants of health and vision loss, preferences for AMD monitoring, and the launch of a new multimedia series.
Read More
Ursula Schmidt-Erfurth, MD: Therapeutic Effect of Pegcetacoplan on GA Disease Activity
May 3rd 2023At ARVO 2023, Schmidt-Erfurth discusses new insights regarding disease activity in GA, observing reductions in both RPE and photoreceptor degeneration after intravitreal pegcetacoplan therapy in the OAKS and DERBY trials.
Read More